Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
and pharmaceutical giant Pfizer (PFE), has set its sights on Kenvue (KVUE). The Wall Street Journal reported Starboard ...
AI search startup Perplexity aims for $8B valuation in new round. UBS sells 50% interest in Swisscard to Amex - report.
Starboard Values Investment in Kenvue Inc. Activist hedge fund Starboard Value has taken a sizeable stake in Kenvue Inc., ...
Some of the steam is coming out of Wall Street’s record-breaking rally, as U.S. stocks edge back from their all-time highs. The S&P 500 was 0.1% lower in early trading Monday, coming off its sixth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback